184 related articles for article (PubMed ID: 15551407)
1. CD5-negative chronic lymphocytic leukemia with indolent clinical course and autoimmune thrombocytopenia, successfully treated with rituximab.
Okamoto M; Nakano S; Namura K; Yamada N; Uchida R; Fuchida S; Okano A; Ochiai N; Shimazaki C
Am J Hematol; 2004 Dec; 77(4):413-5. PubMed ID: 15551407
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous manifestation of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).
Sokol L; Agosti SJ
Am J Hematol; 2004 Feb; 75(2):107-9. PubMed ID: 14755378
[TBL] [Abstract][Full Text] [Related]
3. CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?
Sheikh SS; Kallakury BV; Al-Kuraya KA; Meck J; Hartmann DP; Bagg A
Am J Hematol; 2002 Dec; 71(4):306-10. PubMed ID: 12447961
[TBL] [Abstract][Full Text] [Related]
4. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
5. Association between immune thrombocytopenic purpura and chronic lymphocytic leukemia in a patient carrier of anti-hepatitis C virus antibodies.
Numeroso F; Baroni MC; Delsignore R
Ann Ital Med Int; 2005; 20(3):197-202. PubMed ID: 16250187
[TBL] [Abstract][Full Text] [Related]
6. CD5+ chronic B-cell leukemia with features intermediate to chronic lymphocytic leukemia and hairy cell leukemia.
Aljurf M; Cornbleet PJ; Michel F
Hematol Pathol; 1994; 8(3):99-109. PubMed ID: 7527021
[TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic leukemia.
Keating MJ
Semin Oncol; 1999 Oct; 26(5 Suppl 14):107-14. PubMed ID: 10561025
[TBL] [Abstract][Full Text] [Related]
8. [B-cell chronic lymphocytic leukemia complicated by autoimmune thrombocytopenic purpura].
Komatsuda A; Lee M; Nishinari T; Nishimura S; Chubachi A; Endo Y; Nakamoto Y; Miura A
Rinsho Ketsueki; 1992 Feb; 33(2):200-4. PubMed ID: 1635169
[TBL] [Abstract][Full Text] [Related]
9. A case report: CD8 expression in B-cell chronic lymphocytic leukemia (B-CLL). Prognostic significance of the aberrant CD8 expression.
Brunet C; Bardin N; Oukhouya O; Harlé JR; Zattara-Cannoni H; Dignat-George F; Sampol J
Hematol Cell Ther; 1998 Dec; 40(6):279-82. PubMed ID: 9924928
[TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukaemia CD20 expression is dependent on the genetic subtype: a study of quantitative flow cytometry and fluorescent in-situ hybridization in 510 patients.
Tam CS; Otero-Palacios J; Abruzzo LV; Jorgensen JL; Ferrajoli A; Wierda WG; Lerner S; O'Brien S; Keating MJ
Br J Haematol; 2008 Apr; 141(1):36-40. PubMed ID: 18324964
[TBL] [Abstract][Full Text] [Related]
11. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
12. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
13. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
[TBL] [Abstract][Full Text] [Related]
14. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia].
Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F
Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759
[TBL] [Abstract][Full Text] [Related]
15. Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia.
Huh YO; Keating MJ; Saffer HL; Jilani I; Lerner S; Albitar M
Am J Clin Pathol; 2001 Sep; 116(3):437-43. PubMed ID: 11554173
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric analysis of CD5+ B cells: a frame of reference for minimal residual disease analysis in chronic lymphocytic leukemia.
Gupta R; Jain P; Deo SV; Sharma A
Am J Clin Pathol; 2004 Mar; 121(3):368-72. PubMed ID: 15023041
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of flow cytometry in the chronic lymphoid leukemias.
DiGiuseppe JA; Borowitz MJ
Semin Oncol; 1998 Feb; 25(1):6-10. PubMed ID: 9482521
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis.
Amato D; Oscier DG; Davis Z; Mould S; Zheng J; Kolomietz E; Wang C
Am J Clin Pathol; 2007 Aug; 128(2):333-8. PubMed ID: 17638670
[TBL] [Abstract][Full Text] [Related]
19. Relationship between autoimmune phenomena and disease stage and therapy in B-cell chronic lymphocytic leukemia.
Barcellini W; Capalbo S; Agostinelli RM; Mauro FR; Ambrosetti A; Calori R; Cortelezzi A; Laurenti L; Pogliani EM; Pedotti P; Liso V; Girelli G; Mandelli F; Zanella A;
Haematologica; 2006 Dec; 91(12):1689-92. PubMed ID: 17145607
[TBL] [Abstract][Full Text] [Related]
20. The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
Rawstron AC; Bennett F; Hillmen P
Br J Haematol; 2007 Dec; 139(5):724-9. PubMed ID: 18021087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
